RxDoctor Payments Data

Tammy Eisentrout, DO

Family Medicine · Canton, OHNPI 1669437844

Payments from drug & device makers

$9,580in general payments, 2019–2025

Across 672 payments — averaging $14.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$1K
  • Novo Nordisk$1K
  • Pfizer$667
  • Lilly USA, LLC$630
  • GSK$624
  • plus $4K from 33 others

What the payments were for

  • Food & beverage$9,573100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,580 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$44,381
Medicare patients
110
Services billed
692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin30$27,025
OzempicSemaglutide17$22,788
MounjaroTirzepatide19$19,756
JanuviaSitagliptin Phosphate11$15,245
TrulicityDulaglutide14$13,686
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$12,331
Methylphenidate ErMethylphenidate Hcl46$3,300
Atorvastatin Calcium397$2,469
Metoprolol Succinate194$2,349
Albuterol Sulfate HfaAlbuterol Sulfate68$1,937
Levothyroxine Sodium248$1,743
Lisinopril243$1,002
Alendronate Sodium151$996
Omeprazole95$995
Buspirone Hcl49$872

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$630$33,44233 claims
Boehringer IngelheimJardiance$231$27,02530 claims
Novo NordiskOzempic$1,070$22,78817 claims
MerckJanuvia$486$15,24511 claims
AstraZenecaBreztri Aerosphere$1,204$12,33114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →